Clinical Trial Update: Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating donor umbilical cord blood natural killer cells with aldesleukin and umbilical cord blood transplant in refractory hematologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Aldesleukin (interleukin-2)
• Umbilical Cord Blood Natural Killer Cells
• Umbilical Cord Blood Transplant

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED | Results posted: 2009-12-31